发明名称 Pyrazolopyridine kinase inhibitors
摘要 The present invention relates to compounds of pyrazolopyridine derivatives useful as inhibitors of protein kinase. In one embodiment the compounds of the present invention are represented by the following structural formula:; or a pharmaceutically acceptable salt thereof.
申请公布号 US9067932(B2) 申请公布日期 2015.06.30
申请号 US201113014505 申请日期 2011.01.26
申请人 Vertex Pharmaceuticals Incorporated 发明人 Boyall Dean;Brenchley Guy;Davis Chris;Fraysse Damien;Golec Julian;Jimenez Juan-Miguel;Miller Andrew;Settimo Luca;Twin Heather;Young Stephen
分类号 C07D471/04;A61K31/496;A61K31/437 主分类号 C07D471/04
代理机构 代理人 Stewart Rory C.
主权项 1. A compound represented by the following structural formula:or a pharmaceutically acceptable salt thereof, wherein: T is —NH— or absent; each Jc1 and Jc2 is independently —CN, —F, —Cl, —OR, —CH2OR, or —CF3; each U1, U2, and U3 is independently —H, Z, or Jb wherein no more than one of U1, U2, and U3 is —H; or two of U1, U2, and U3 join together to form a C1-C6 cyloalkyl ring having 0-1 heteroatoms independently substituted with one or more Je; Z is Y2-Q2; Y2 is absent or C1-6 alkyl optionally and independently substituted with one or more Jd; Q2 is absent or C3-C8 cyloalkyl having 0-1 heteroatoms optionally and independently substituted with one or more Je, wherein Y2 and Q2 are not both absent; each Jb is independently —F, —OR, —CN, —CF3, —N(R)2, —C(O)N(R)2, C1-6 alkyl optionally and independently substituted with one or more Ja; each Ja is independently —F, —OR, —N(R)2, or —C(O)N(R)2; each Jd is independently —OR, —CN, —C(O)N(R)2, —N(R)2 or F; each Je is independently C1-C6 alkyl, —OR, —N(R)2, CF3, or F; each R is —H or C1-C6 alkyl; and wherein there is a chiral center at the carbon indicated by *, and wherein (S) represents stereochemistry on the ring carbon; with the proviso that the compound is not:
地址 Boston MA US